Messaging plus incentive for Flu Vaccine

N/A

Waitlist Available

Research Sponsored by The University of Texas Health Science Center at Tyler

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up three months

Awards & highlights

No Placebo-Only Group

Summary

• This study will assess the effect of promotional messaging and incentives encouraging influenza vaccination in the Sendero IdealCare policy holders during the 2018-2019 Flu Season. The intervention will consist of influenza vaccination promotion/reminders from Sendero Health Plans to subscribers, including text messages, emails, and tailored direct mail outs, i.e. postcard or a personalized letter, and incentive. The study population consists of approximately 22,500 subscribers enrolled in Sendero IdealCare Plan. The intervention will last approximately four months. The primary endpoints, assessed through administrative claims data, will be getting a flu shot during the 2018-2019 season. Data collected through this study will be used to determine effective components of influenza vaccination promotion campaigns used by a health insurance plan.

Eligible Conditions

Flu Vaccine

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ three months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~three months

This trial's timeline: 3 weeks for screening, Varies for treatment, and three months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Influenza vaccination

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Messaging plus incentiveExperimental Treatment2 Interventions

Group will be sent flu vaccine promotion messages via text, email and U.S. Mail, and will be eligible to receive a gift card as incentive for receiving flu vaccine

Group II: MessagingExperimental Treatment1 Intervention

Group will be sent flu vaccine promotion messages via text, email and U.S. Mail

Group III: ControlActive Control1 Intervention

No intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Messaging

2022

N/A

~79480